crohn's disease and glp-1 The role of RA in inflammatory bowel disease. The GLP-1 RA Gut Hormones and Inflammatory Bowel

Description

Common gastrointestinal side effects include: Nausea and vomiting (affecting 1540% of patients, depending on the specific medication and dose) [13] [16] Diarrhoea (reported in 1030% of patients) Constipation (affecting 1020% of patients) Abdominal pain and discomfort Reduced appetite and early satiety Dyspepsia and gastro-oesophageal reflux symptoms These effects are generally dose-dependent and tend to improve over time as the body adjusts to the medication

[DOI] [PubMed] [Google Scholar] 41.Effects of liraglutide versus placebo on cardiovascular events in patients with type 2 diabetes mellitus and chronic kidney disease

They also stop your liver from making too much sugar

Mend your fences: the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease

JAMA Internal Medicine (2016): In over 1.5 million patients, incretin-based drugs, including GLP-1s, had an adjusted hazard ratio of 1.04 (95% CI, 0.811.35) for acute pancreatitis